What this deck covers
This deck focuses on Iv Therapy Complications Infiltration Extravasation, giving you a quick way to review the definitions, rules, and examples that matter most for Nclexrn.
Study Iv Therapy Complications Infiltration Extravasation in Nclexrn with focused flashcards that help you recognize the idea, recall the key rule, and apply it in practice-style prompts.
0% Complete
Which finding most strongly suggests extravasation rather than simple infiltration?
Tap card or press Space to flip
Blistering or skin necrosis near the IV site. Vesicant drugs cause direct tissue injury, progressing to blisters or necrosis, unlike nonvesicant infiltration which rarely leads to such severe damage.
How well did you know it?
Card 1 / 25
Space to flip · ← / → to move · once flipped, → Got it · ← Still learning
This deck focuses on Iv Therapy Complications Infiltration Extravasation, giving you a quick way to review the definitions, rules, and examples that matter most for Nclexrn.
Work through these flashcards in short sessions. Try to answer each prompt before flipping the card, then revisit any cards you miss until the explanation feels automatic.
Answer: Blistering or skin necrosis near the IV site. Vesicant drugs cause direct tissue injury, progressing to blisters or necrosis, unlike nonvesicant infiltration which rarely leads to such severe damage.
Answer: Cold compress (unless antidote/drug protocol specifies warm). Cold induces vasoconstriction, localizing vesicant and limiting its spread, unless protocol indicates warmth for dispersion.
Answer: Leakage of vesicant medication into surrounding tissue. Extravasation happens when vesicant drugs leak from vein, potentially causing tissue irritation, blistering, or necrosis due to their caustic nature.
Answer: Warm compress (unless drug-specific guidance differs). Warmth enhances circulation and absorption of nonvesicant fluid, aiding resolution of edema unless contraindicated by specific guidelines.
Answer: Stop the infusion immediately. Halting infusion prevents further leakage, minimizing tissue exposure and potential damage from continued fluid or drug extravasation.
Answer: Aspirate residual medication from the catheter if possible. Aspiration removes remaining vesicant from site, reducing tissue exposure and injury severity before catheter removal.
Answer: Remove the catheter after aspiration and per facility protocol. Catheter is retained briefly for aspiration or antidote, then removed to avoid further leakage per standard protocols.
Answer: Leakage of nonvesicant IV fluid into surrounding tissue. Infiltration occurs when IV catheter dislodges, allowing non-irritating fluid to escape vein into tissue, causing local swelling without severe damage.
Answer: Pallor or blanching at the IV site. Fluid accumulation constricts local blood flow, leading to pale or blanched skin as an early visual cue of infiltration.
Answer: Swelling (edema) around the insertion site. Edema develops as leaked fluid accumulates in interstitial space, serving as an early indicator before other symptoms like pain or coolness appear.
Answer: Extravasation involves a vesicant; infiltration involves a nonvesicant. The distinction lies in the fluid type: vesicants in extravasation cause tissue damage, while nonvesicants in infiltration typically result in mild edema.
Answer: Verify blood return and assess site frequently during infusion. Regular checks confirm patency and early detection of issues, preventing progression to significant infiltration or extravasation.
Answer: Use the smallest gauge that meets therapy needs. Smaller gauges minimize vein wall trauma and irritation, lowering risk of perforation and subsequent leakage.
Answer: Weak distal pulse or delayed capillary refill. Significant infiltration can cause compartment syndrome-like effects, compressing vessels and impairing distal circulation.
Answer: Older adults. Aging thins vein walls and reduces elasticity, increasing susceptibility to catheter dislodgement and fluid leakage.
Answer: Large, stable vein (often forearm) and avoid hand/wrist when possible. Larger veins in stable areas like forearm provide better tolerance and less movement, reducing dislodgement risk during vesicant infusion.
Answer: Burning, stinging, or severe pain at the IV site. Vesicants irritate tissues upon leakage, eliciting intense localized pain as a critical early symptom requiring immediate intervention.
Answer: Site assessment, drug/solution, actions taken, patient response, and notifications. Comprehensive records support continuity of care, legal protection, and evaluation of incident response effectiveness.
Answer: Disconnect tubing while leaving the catheter in place initially. Disconnecting tubing stops drug flow while preserving catheter access for potential aspiration or antidote administration.
Answer: Stop infusion, keep catheter for aspiration/antidote, then follow protocol. Immediate cessation halts further leakage, with catheter retention allowing drug removal or antidote delivery per guidelines.
Answer: Notify the provider and follow the facility extravasation protocol. Provider notification ensures prompt medical intervention, while protocol adherence guides antidote use and monitoring.
Answer: Flushing the IV line. Flushing forces more vesicant into tissues, exacerbating damage, so it's avoided to prevent worsening extravasation.
Answer: Coolness at and around the IV site. Leaked cool IV fluid lowers local tissue temperature, distinguishing infiltration from phlebitis, which often presents with warmth.
Answer: Elevate the affected extremity. Elevation promotes venous return and reduces edema by facilitating fluid drainage from the affected area.
Answer: Slowed or stopped infusion, often with pump occlusion alarm. Tissue resistance from edema impedes flow, triggering pump alarms as pressure builds without proper venous return.